RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 109 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34 | -82.8% | 31,493 | -79.0% | 0.00% | -100.0% |
Q1 2023 | $198 | -99.8% | 149,771 | +46.8% | 0.00% | +100.0% |
Q3 2022 | $120,000 | -46.4% | 102,058 | -48.5% | 0.00% | -50.0% |
Q2 2022 | $224,000 | +187.2% | 198,210 | +576.3% | 0.00% | – |
Q4 2021 | $78,000 | -73.9% | 29,307 | -64.4% | 0.00% | -100.0% |
Q3 2021 | $299,000 | +443.6% | 82,275 | +545.0% | 0.00% | – |
Q2 2021 | $55,000 | -57.4% | 12,756 | -66.3% | 0.00% | -100.0% |
Q1 2021 | $129,000 | -91.6% | 37,810 | -91.3% | 0.00% | -87.5% |
Q4 2020 | $1,528,000 | +730.4% | 436,450 | +469.9% | 0.01% | +700.0% |
Q3 2020 | $184,000 | +776.2% | 76,579 | +564.4% | 0.00% | – |
Q2 2020 | $21,000 | -90.5% | 11,526 | -91.8% | 0.00% | -100.0% |
Q1 2020 | $220,000 | +368.1% | 141,165 | +540.0% | 0.00% | – |
Q4 2019 | $47,000 | +23.7% | 22,056 | +9.4% | 0.00% | – |
Q3 2019 | $38,000 | -30.9% | 20,160 | -6.2% | 0.00% | -100.0% |
Q1 2019 | $55,000 | -37.5% | 21,482 | -31.3% | 0.00% | 0.0% |
Q2 2018 | $88,000 | +41.9% | 31,262 | +79.8% | 0.00% | – |
Q1 2018 | $62,000 | +12.7% | 17,388 | +21.7% | 0.00% | -100.0% |
Q4 2017 | $55,000 | -63.6% | 14,283 | -76.0% | 0.00% | 0.0% |
Q3 2017 | $151,000 | +387.1% | 59,401 | +415.2% | 0.00% | – |
Q2 2017 | $31,000 | -29.5% | 11,529 | -13.9% | 0.00% | – |
Q1 2017 | $44,000 | -51.6% | 13,398 | -65.0% | 0.00% | -100.0% |
Q4 2016 | $91,000 | +65.5% | 38,257 | +45.6% | 0.00% | – |
Q1 2016 | $55,000 | -16.7% | 26,280 | +21.5% | 0.00% | – |
Q4 2015 | $66,000 | -2.9% | 21,635 | -38.6% | 0.00% | – |
Q3 2014 | $68,000 | +21.4% | 35,221 | +126.2% | 0.00% | – |
Q3 2013 | $56,000 | – | 15,574 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |